COVID-19: Perceived Infection Risk and Barriers to Uptake of Pfizer-BioNTech and Moderna Vaccines Among Community Healthcare Workers

被引：0
|
作者：
Tolulope B. Famuyiro
Abayomi Ogunwale
Jude des Bordes
Mukaila Raji
机构：
[1] The University of Texas McGovern Medical School,Department of Family and Community Medicine
[2] University of Texas Medical Branch,Division of Geriatrics and Palliative Medicine Department of Internal Medicine Department of Preventive Medicine and Population Health
来源：
Journal of Racial and Ethnic Health Disparities | 2022年 / 9卷
关键词：
COVID-19 vaccine; Vaccine uptake; Vaccine hesitance; Healthcare workers; COVID-19;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1543 / 1549
页数：6
相关论文
共 50 条
  • [31] Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions
    Haq, Hannah N.
    Khan, Hafiz
    Chaudhry, Haroon
    Nimmala, Swathi
    Demidovich, Joseph
    Papudesi, Bhavani Nagendra
    Potluri, Sai Deepika
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2022, 114 (06) : 601 - 612
  • [32] Minimal Change Disease Secondary to Either COVID-19 Infection or Pfizer-BioNTech COVID-19 Vaccination
    Pokharel, A.
    Li, W.
    Kanaan, H. D.
    Zhang, P.
    Blatt, N. B.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (SUPP 1) : S154 - S154
  • [33] Minimal risk of GBS relapse after Pfizer-BioNTech COVID-19 vaccination
    Reactions Weekly, 2021, 1873 (1) : 12 - 12
  • [34] Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021
    Tenforde, Mark W.
    Olson, Samantha M.
    Self, Wesley H.
    Talbot, H. Keipp
    Lindsell, Christopher J.
    Steingrub, Jay S.
    Shapiro, Nathan, I
    Ginde, Adit A.
    Douin, David J.
    Prekker, Matthew E.
    Brown, Samuel M.
    Peltan, Ithan D.
    Gong, Michelle N.
    Mohamed, Amira
    Khan, Akram
    Aline, Matthew C.
    Files, D. Clark
    Gibbs, Kevin W.
    Stubblefield, William B.
    Casey, Jonathan D.
    Rice, Todd W.
    Grijalva, Carlos G.
    Hager, David N.
    Shehu, Arber
    Qadir, Nida
    Chang, Steven Y.
    Wilson, Jennifer G.
    Gaglani, Manjusha
    Murthy, Kempapura
    Calhoun, Nicole
    Monto, Arnold S.
    Martin, Emily T.
    Malani, Anurag
    Zimmerman, Richard K.
    Silveira, Fernanda P.
    Middleton, Donald B.
    Zhu, Yuwei
    Wyatt, Dayna
    Stephenson, Meagan
    Baughman, Adrienne
    Womack, Kelsey N.
    Hart, Kimberly W.
    Kobayashi, Miwako
    Verani, Jennifer R.
    Patel, Manish M.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (18): : 674 - 679
  • [35] Eczematiform eruption after Pfizer-BioNTech COVID-19 vaccineMots
    Bekkali, Nihal
    Allard, Tanguy
    Lengelle, Celine
    Esteve, Eric
    THERAPIE, 2021, 76 (04): : 364 - 365
  • [36] A Bullous Eruption following the Pfizer-BioNTech COVID-19 vaccination
    D'Cruz, A.
    Parker, H.
    Saha, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (12) : E864 - E865
  • [37] Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine
    Reactions Weekly, 2021, 1862 (1) : 11 - 11
  • [38] Granulomatosis with polyangiitis following Pfizer-BioNTech COVID-19 vaccination
    Shirai, Tsuyoshi
    Suzuki, Jun
    Kuniyoshi, Shimpei
    Tanno, Yuito
    Fujiia, Hiroshi
    MODERN RHEUMATOLOGY CASE REPORTS, 2023, 7 (01) : 127 - 129
  • [39] Pfizer-BioNTech COVID-19 vaccine safe in older Koreans
    Reactions Weekly, 2021, 1884 (1) : 10 - 10
  • [40] AEs in children after Pfizer-BioNTech COVID-19 vaccine
    Reactions Weekly, 2022, 1930 (1) : 7 - 7
12345